149 related articles for article (PubMed ID: 37853623)
21. Primary appendicular hemangiosarcoma and telangiectatic osteosarcoma in 70 dogs: A Veterinary Society of Surgical Oncology retrospective study.
Giuffrida MA; Kamstock DA; Selmic LE; Pass W; Szivek A; Mison MB; Boston SE; Fox LE; Robat C; Grimes JA; Maritato KC; Bacon NJ
Vet Surg; 2018 Aug; 47(6):774-783. PubMed ID: 30051473
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of tumour-related factors associated with canine retroperitoneal hemangiosarcoma in comparison with other anatomic presentations: A retrospective observational study.
Furukawa T; Shiotsuki A; Okada Y; Nibe K; Tei M; Anazawa T; Yoshikawa M; Ono K; Hirao H
Vet Med Sci; 2024 Jul; 10(4):e1495. PubMed ID: 38889089
[TBL] [Abstract][Full Text] [Related]
25. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
Gedney A; Salah P; Mahoney JA; Krick E; Martins R; Scavello H; Lenz JA; Atherton MJ
Vet Comp Oncol; 2022 Sep; 20(3):688-696. PubMed ID: 35442554
[TBL] [Abstract][Full Text] [Related]
27. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
[TBL] [Abstract][Full Text] [Related]
28. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
29. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
[TBL] [Abstract][Full Text] [Related]
30. Treatment of retroperitoneal sarcoma results in improved outcomes.
Walter KM; Culp WTN; Giuffrida MA; Amsellem P; Wallace ML; Grimes JA; Wustefeld-Janssens B; O'Neill M; Withers SS; Shannon D; Lapsley J; Tuohy J; Hixson H; Lux CN; Matz B; Selmic LE; McGrath A; Griffin MA; Mayhew PD; Steffey MA; Balsa IM; Rebhun RB; Kent MS
J Am Vet Med Assoc; 2024 Jul; 262(7):1-9. PubMed ID: 38382204
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
33. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
[TBL] [Abstract][Full Text] [Related]
34. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
35. Primary rib tumors in 54 dogs.
Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
[TBL] [Abstract][Full Text] [Related]
36. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
Alexander CK; Cronin KL; Silver M; Gardner HL; London C
J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
[TBL] [Abstract][Full Text] [Related]
37. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
Locke JE; Barber LG
J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
[TBL] [Abstract][Full Text] [Related]
38. Treatment with DAV for advanced-stage hemangiosarcoma in dogs.
Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE
J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment of conjunctival hemangioma and hemangiosarcoma: A retrospective study of 52 dogs.
Richardson S; Deykin AR
Vet Ophthalmol; 2021 Sep; 24(5):432-441. PubMed ID: 34402571
[TBL] [Abstract][Full Text] [Related]
40. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review.
MacEwen EG; Kurzman ID; Helfand S; Vail D; London C; Kisseberth W; Rosenthal RC; Fox LE; Keller ET; Obradovich J
J Drug Target; 1994; 2(5):391-6. PubMed ID: 7704483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
